Tcg Fluent Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TCG FLUENT PHARMA, and when can generic versions of TCG FLUENT PHARMA drugs launch?
TCG FLUENT PHARMA has one approved drug.
There are two US patents protecting TCG FLUENT PHARMA drugs.
There are eight patent family members on TCG FLUENT PHARMA drugs in twelve countries and five supplementary protection certificates in five countries.
Summary for Tcg Fluent Pharma
International Patents: | 8 |
US Patents: | 2 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Tcg Fluent Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tcg Fluent Pharma | FLOLIPID | simvastatin | SUSPENSION;ORAL | 206679-002 | Apr 21, 2016 | RX | Yes | Yes | 10,300,041 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Tcg Fluent Pharma | FLOLIPID | simvastatin | SUSPENSION;ORAL | 206679-001 | Apr 21, 2016 | RX | Yes | No | 9,597,289 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Tcg Fluent Pharma | FLOLIPID | simvastatin | SUSPENSION;ORAL | 206679-002 | Apr 21, 2016 | RX | Yes | Yes | 9,597,289 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Tcg Fluent Pharma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Portugal | 2018153 | ⤷ Sign Up |
Slovenia | 2018153 | ⤷ Sign Up |
Cyprus | 1112917 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Tcg Fluent Pharma Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0720599 | C300172 | Netherlands | ⤷ Sign Up | PRODUCT NAME: EZETIMIBE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, EN SIMVASTATINE; NAT. REGISTRATION NO/DATE: RVG 30927RVG 30928RVG 30929RVG 30930 2004221122; FIRST REGISTRATION: 58874.00.0058874.01.0058874.02.0058874.03.0058878.00.0058878.01.0058878.02.0058878.03.0058866.00.0058866.01.0058866.02.0058866.03.0058870.00.0058870.01.0058870.02.0058870.03.00 2004020402 |
0720599 | SPC/GB05/010 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: EZETIMIBE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN COMBINATION WITH SIMVASTATIN; REGISTERED: DE 58874.00.00 20040402; DE 58874.01.00 20040402; DE 58874.02.00 20040402; DE 58874.03.00 20040402; DE 58878.00.00 20040402; DE 58878.01.00 20040402; DE 58878.02.00 20040402; DE 58878.03.00 20040402; DE 58866.00.00 20040402; DE 58866.01.00 20040402; DE 58866.02.00 20040402; DE 58866.03.00 20040402; DE 58870.00.00 20040402; DE 58870.01.00 20040402; DE 58870.02.00 20040402; DE 58870.03.00 20040402; UK PL 19945/0003 20041118; UK PL 19945/0004 20041118; UK PL 19945/0005 20041118; UK PL 19945/0006 20041118; UK PL 19945/0007 20041118; UK PL 19945/0008 20041118; UK PL 19945/0009 200411 |
0720599 | 26/2005 | Austria | ⤷ Sign Up | PRODUCT NAME: EZETIMIB ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON KOMBINIERT MIT SIMVASTATIN; NAT. REGISTRATION NO/DATE: 1-25673 - 1-25676 20041228; FIRST REGISTRATION: DE 58874.00.00 - 58874.03.00; 58878.00.00 - 20040402 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.